4.5
Chronisch obstruktive Lungenerkrankung V: Behandlung
Die Behandlung der chronisch obstruktiven Lungenerkrankung (COPD) erfordert einen vielschichtigen Ansatz, um die Symptome zu lindern, Exazerbationen v…
Die Behandlung chronisch obstruktiver Lungenerkrankung (COPD) umfasst mehrere Schlüsselkomponenten.
Erstens ist die Raucherentwöhnung von entscheidender Bedeutung. Gesundheitsdienstleister klären COPD-Patienten über die Risiken des Rauchens auf und helfen ihnen, ein bestimmtes "Aufhördatum" festzulegen, um das Aufhören zu erleichtern.
Als nächstes beinhaltet die pharmakologische Therapie die Verwendung von Bronchodilatatoren, zu denen kurzwirksame Beta-Agonisten, kurzwirksame Anticholinergika, langwirksame Beta-Agonisten, lang wirkende Anticholinergika sowie entzündungshemmende Mittel, Kortikosteroide, Mukolytika und Phosphodiesterase-4-Hemmer gehören.
Diese Medikamente werden über unter Druck stehende Dosierinhalatoren, Kleinmengenvernebler und Trockenpulverinhalatoren verabreicht.
Die Sauerstofftherapie wird eingeleitet, wenn die Sauerstoffsättigung in Ruhe oder während des Trainings unter 88 % fällt. Es kann mit Nasenkanülen, Masken oder transtrachealen Systemen verabreicht werden.
Darüber hinaus werden pulmonale Rehabilitationsprogramme wie Bewegungstraining, Bildung und emotionale Unterstützung angeboten.
Schließlich können bei schwerer COPD chirurgische Optionen wie eine Operation zur Reduzierung des Lungenvolumens, eine Bullektomie oder eine Lungentransplantation in Betracht gezogen werden.
View the full transcript and gain access to JoVE Core videos
Q1: Why is smoking cessation the first step in COPD management?
Smoking cessation is the most critical intervention for COPD patients who smoke because it slows disease progression, reduces exacerbation frequency, and improves lung function. Healthcare providers educate patients about smoking risks and help establish a specific quit date. Methods include behavioral therapy, nicotine replacement therapy, and medications like bupropion or varenicline to support successful cessation.
Q2: What types of bronchodilators are used to treat COPD?
COPD treatment uses both short-acting and long-acting bronchodilators. Short-acting beta-agonists and anticholinergics relieve acute symptoms, while long-acting beta-agonists and anticholinergics provide long-term symptom control. These medications are administered via pressurized metered-dose inhalers, small-volume nebulizers, or dry-powder inhalers depending on patient preference and clinical need.
Q3: When is oxygen therapy initiated in COPD patients?
Oxygen therapy begins when oxygen saturation drops below 88% at rest or during exercise. Long-term oxygen therapy improves survival, enhances quality of life, and increases exercise capacity in patients with severe resting hypoxemia. Oxygen can be delivered via nasal cannulas, masks, or transtracheal systems based on individual patient needs and activity levels.
Q4: What role do corticosteroids play in COPD management?
Inhaled corticosteroids are often combined with long-acting bronchodilators, particularly for patients with frequent exacerbations. Oral corticosteroids treat acute exacerbations but should be avoided for long-term use due to significant side effects including osteoporosis, hyperglycemia, and muscle weakness. Anti-inflammatory agents work alongside corticosteroids to reduce airway inflammation.
Q5: How does pulmonary rehabilitation support COPD patients?
Pulmonary rehabilitation programs provide exercise training, nutritional counseling, and education to improve physical and emotional participation and overall quality of life. These programs also include airway clearance techniques such as chest physiotherapy and postural drainage to help clear mucus. Emotional support addresses anxiety and depression, which are common comorbidities in chronic obstructive pulmonary disease patients.
Q6: What surgical options are available for severe COPD?
Surgical interventions for severe COPD include bullectomy, which removes large bullae to improve lung function in selected patients, and lung volume reduction surgery, which removes damaged lung tissue to enhance function and quality of life in emphysema cases. Lung transplantation is considered in advanced COPD when other treatments have failed, requiring careful patient selection and multidisciplinary evaluation.
Q7: What supportive therapies complement pharmacologic COPD management?
Supportive therapies include annual influenza and pneumococcal vaccinations to prevent infections, nutritional support to address undernutrition, and regular physical activity to improve strength and endurance. Management of comorbidities such as cardiovascular disease, osteoporosis, anxiety, and depression is essential. A multidisciplinary team including pulmonologists, nurses, physical therapists, and dietitians provides comprehensive individualized care.